Novo Nordisk reported DKK32.38B in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Bausch Health Companies USD 719M 2M Dec/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Merck USD 6.24B 318M Dec/2025
Novartis USD 4.5B 363M Sep/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Novo Nordisk DKK 5.18B 33.61B Jun/2025
Pacira USD 13.15M 2.92M Sep/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.32M Sep/2025